Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Approximately 25% of adults regularly experience heartburn, a symptom of gastro-oesophageal reflux disease (GORD). Most patients are treated empirically (without specific diagnostic evaluation e.g. endoscopy. Among patients who have an upper endoscopy, findings range from a normal appearance, mild erythema to severe oesophagitis with stricture formation. Patients without visible damage to the oesophagus have endoscopy negative reflux disease (ENRD). The pathogenesis of ENRD, and its response to treatment may differ from GORD with oesophagitis. OBJECTIVES: Summarise, quantify and compare the efficacy of short-term use of proton pump inhibitors (PPI), H2-receptor antagonists (H2RA) and prokinetics in adults with GORD, treated empirically and in those with endoscopy negative reflux disease (ENRD). SEARCH METHODS: We searched MEDLINE (January 1966 to November 2011), EMBASE (January 1988 to November 2011), and EBMR in November 2011. SELECTION CRITERIA: Randomised controlled trials reporting symptomatic outcome after short-term treatment for GORD using proton pump inhibitors, H2-receptor antagonists or prokinetic agents. Participants had to be either from an empirical treatment group (no endoscopy used in treatment allocation) or from an endoscopy negative reflux disease group (no signs of erosive oesophagitis). DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial quality and extracted data. MAIN RESULTS: Thirty-four trials (1314 participants) were included: fifteen in the empirical treatment group, fifteen in the ENRD group and four in both. In empirical treatment of GORD the risk ratio (RR) for heartburn remission (the primary efficacy variable) in placebo-controlled trials for PPI was 0.37 (two trials, 95% confidence interval (CI) 0.32 to 0.44), for H2RAs 0.77 (two trials, 95% CI 0.60 to 0.99) and for prokinetics 0.86 (one trial, 95% CI 0.73 to 1.01). In a direct comparison PPIs were more effective than H2RAs (seven trials, RR 0.66, 95% CI 0.60 to 0.73) and prokinetics (two trials, RR 0.53, 95% CI 0.32 to 0.87).In treatment of ENRD, the RR for heartburn remission for PPI versus placebo was 0.71 (ten trials, 95% CI 0.65 to 0.78) and for H2RA versus placebo was 0.84 (two trials, 95% CI 0.74 to 0.95). The RR for PPI versus H2RA was 0.78 (three trials, 95% CI 0.62 to 0.97) and for PPI versus prokinetic 0.72 (one trial, 95% CI 0.56 to 0.92). AUTHORS' CONCLUSIONS: PPIs are more effective than H2RAs in relieving heartburn in patients with GORD who are treated empirically and in those with ENRD, although the magnitude of benefit is greater for those treated empirically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J., Jones, R., & the Global Consensus Group (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00630.x · Cited by 3,924
Locke, G., Talley, N., Fett, S., Zinsmeister, A., & Melton, L. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70025-8 · Cited by 2,095
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6514 · Cited by 1,385
Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41217.x · Cited by 1,130
Symptomatic gastroesophageal reflux: Incidence and precipitating factors
Nebel, O. T., Fornes, M. F., & Castell, D. O. (1976) · The American Journal of Digestive Diseases · doi:10.1007/bf01071906 · Cited by 874
Chiba, N., De Gara, C., Wilkinson, J., & Hunt, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178669 · Cited by 857
Symptoms in gastro-oesophageal reflux disease
Klauser, A. G., Schindlbeck, N. E., & Müller-Lissner, S. A. (1990) · The Lancet · doi:10.1016/0140-6736(90)90287-f · Cited by 745
Updated Guidelines for The Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.1123_a.x · Cited by 544
Carlsson, R., Dent, J., Watts, R., Riley, S., Sheikh, R., Hatlebakk, J., Haug, K., de Groot, G., van Oudvorst, A., Dalväg, A., et al. (1998) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199802000-00004 · Cited by 435
Cited by
Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J., Jones, R., & the Global Consensus Group (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00630.x · Cited by 3,924
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Gerson, L. B., & Vela, M. F. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.444 · Cited by 1,767
Rosen, R., Vandenplas, Y., Singendonk, M., Cabana, M., DiLorenzo, C., Gottrand, F., Gupta, S., Langendam, M., Staiano, A., Thapar, N., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001889 · Cited by 1,557
Fitzgerald, R. C., di Pietro, M., Ragunath, K., Ang, Y., Kang, J.-Y., Watson, P., Trudgill, N., Patel, P., Kaye, P. V., Sanders, S., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305372 · Cited by 1,346
Update of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
“[81] The efficacy of PPI in the treatment of GERD in the general population is well documented in meta-analyses of RCTs.[82-84] In asymptomatic SSc patients, PPI should be used with caution since long-term therapy with PPIs might lead to nutritional deficiencies, possibly due to reduced intestinal absorption, or incre…”
Background25 Years of Proton Pump Inhibitors: A Comprehensive Review
Strand, D. S., Kim, D., & Peura, D. A. (2017) · Gut and Liver · doi:10.5009/gnl15502 · Cited by 671
Kowal-Bielecka, O., Landewé, R., Avouac, J., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096677 · Cited by 619
External Validation of a Measurement Tool to Assess Systematic Reviews (AMSTAR)
Shea, B. J., Bouter, L. M., Peterson, J., Boers, M., Andersson, N., Ortiz, Z., Ramsay, T., Bai, A., Shukla, V. K., & Grimshaw, J. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001350 · Cited by 569
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
Panula, P., Chazot, P. L., Cowart, M., Gutzmer, R., Leurs, R., Liu, W. L. S., Stark, H., Thurmond, R. L., & Haas, H. L. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010249 · Cited by 575
Control of Gastric Acid Secretion in Health and Disease
Schubert, M. L., & Peura, D. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.021 · Cited by 481
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Kahrilas, P. J., Shaheen, N. J., & Vaezi, M. F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.044 · Cited by 431
Gastro-oesophageal reflux disease
Moayyedi, P., & Talley, N. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68932-0 · Cited by 426
Roman, S., Gyawali, C. P., Savarino, E., Yadlapati, R., Zerbib, F., Wu, J., Vela, M., Tutuian, R., Tatum, R., Sifrim, D., et al. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13067 · Cited by 378
Yadlapati, R., Gyawali, C. P., Pandolfino, J. E., Chang, K., Kahrilas, P. J., Katz, P. O., Katzka, D., Komanduri, S., Lipham, J., Menard-Katcher, P., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.01.025 · Cited by 358
Management of Gastroesophageal Reflux Disease
Gyawali, C. P., & Fass, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.07.049 · Cited by 346
AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review
Targownik, L. E., Fisher, D. A., & Saini, S. D. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.247 · Cited by 320
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shi, S., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0538-y · Cited by 314
Gastroesophageal Reflux Disease
Kahrilas, P. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0804684 · Cited by 288
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015
Iwakiri, K., Kinoshita, Y., Habu, Y., Oshima, T., Manabe, N., Fujiwara, Y., Nagahara, A., Kawamura, O., Iwakiri, R., Ozawa, S., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1227-8 · Cited by 285
Fass, R. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225631.07039.6d · Cited by 270
Using a Drug Facts Box to Communicate Drug Benefits and Harms Two Randomized Trials
Schwartz, L. M., Woloshin, S., & Welch, H. G. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-8-200904210-00106 · Cited by 256
Gastro-oesophageal reflux disease
Fass, R., Boeckxstaens, G. E., El-Serag, H., Rosen, R., Sifrim, D., & Vaezi, M. F. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00287-w · Cited by 237
Potassium-competitive acid blockade: A new therapeutic strategy in acid-related diseases
Andersson, K., & Carlsson, E. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.005 · Cited by 202
Initial management strategies for dyspepsia
Delaney, B., Moayyedi, P., & Forman, D. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001961 · Cited by 181
RetractedPasricha, P. J., Pehlivanov, N., Sugumar, A., & Jankovic, J. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0442 · Cited by 164
Diagnosis and management of non-erosive reflux disease–the Vevey NERD Consensus Group
Modlin, I. M., Hunt, R. H., Malfertheiner, P., Moayyedi, P., Quigley, E. M., Tytgat, G. N. J., Tack, J., Heading, R. C., Holtman, G., & Moss, S. F. (2009) · Digestion · doi:10.1159/000219365 · Cited by 154
Acid Suppression Therapy: Where Do We Go from Here?
Scarpignato, C., Pelosini, I., & Di Mario, F. (2006) · Digestive Diseases · doi:10.1159/000091298 · Cited by 119
Wang, W. H., Huang, J. Q., Zheng, G. F., Xia, H. H. X., Wong, W. M., Liu, X. G., Karlberg, J., & Wong, B. C. Y. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.012 · Cited by 114
Metadata
- Authors
- Sigterman, K. E., van Pinxteren, B., Bonis, P. A., Lau, J., & Numans, M. E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-05-31
- Volume
- 2013
- Issue
- 5
- Pages
- CD002095-CD002095
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1935581134
- Cited by
- 507
- References
- 49
- FWCI
- 28.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.